A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate the multiple dose pharmacokinetics, safety, and tolerability of
two dose strengths of varenicline in adolescents aged 12 to 16 years who regularly smoke at
least three cigarettes per day.